Ampicillin and other modern antibiotics kill a much wider variety of bacteria than penicillin does. They also carry higher profit margins, so drug companies now have an incentive to stop manufacturing the older, less profitable antibiotics. This could cause a penicillin shortage, forcing doctors to use the much more powerful new antibiotics in cases where they might otherwise be unnecessary. Thus, these newer antibiotics are likely to result in an outbreak of diseases caused by drug-resistant bacteria, since __.
The conclusion of the argument is most strongly supported if drug-resistant bacteria flourish in the absence of competition from a wide variety of other bacteria.